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Host immune status in uremia. V. Effect of uremia on resistance to
bacterial infection. Infection is a frequent complication and cause of
death in renal failure. Although it is widely accepted that uremia has an
adverse effect on host resistance to infectious disease, this association
has not been proven. In the present experiments, the relationship
between uremia and susceptibility to infection has been investigated
using an animal model of chronic, severe uremia. Lung infections (using
Pseudomonas aeruginosa and Klebsiella pneumoniae), bacteremia,
peritonitis and subcutaneous infection (using Escherichia coli) were
induced in uremic and normal rats and the course of infection com-
pared. The ability of the uremic host to clear Ps. aeruginosa from the
lung was marginally impaired in the first 24 hr after the challenge but
was normal in the later stages of the infection. Similarly, in the
bacteremia study, secondary invasion of the lungs by several other
species of bacteria occurred in 33% of the uremic animals. We found no
other evidence of impairment of immunity in uremia in the infections
that we studied and, taken overall, the results support arguments that
uremia per se is unlikely to be an important factor predisposing patients
with renal failure to infection.
Etat immun de l'hôte dans l'urémie. V. Effet de l'urémie sur Ia
résistance a l'infection bactérienne. L'infection est une complication
fréquente et une cause de décés dans l'insuffisance rénale. Bien qu'il
soit d'une facon genérale accepté que l'urémie a un effet adverse sur Ia
résistance de l'hôte a Ia maladie infectieuse, cette association n'a pas
été prouvée. Dans ces expénences, Ia relation entre l'urémie et Ia
susceptibilité a l'infection a été étudiée en utilisant un modèle animal
d'urémie chronique sévére. Des infections pulmonaires (en utilisant
Pseudomonas aeruginosa et Kiebseilla pneumoniae) une bactériémie,
une péritonite et une infection sous-cutanée (en utilisant Escherichia
coli) ont été induites chez des rats normaux et urémiques, et les
evolutions de l'infection comparées. La capacite de l'hôte urémique de
dCbarrasser Ic poumon de Ps. aeruginosa Ctait diminuée de facon
modCrCe dans les 24 premieres heures apres l'induction mais était
normale au stade ultCrieur de l'infection. De méme dans l'étude de la
bactCriCmie, une invasion secondaire des poumons par plusieurs autres
especes de bactériés est survenue chez 33% des animaux urCmiques.
Nous n'avons pas trouvC d'autres preuves d'une alteration de l'immun-
itC au cours de l'urémie dans les infections que nous avons étudiées, et,
pris de facon globale, ces résultats sont en faveur de l'idCe que l'urémie
en soi n'est probablement pas un facteur important predisposant a
l'infection les malades atteints d'insuffisance rCnale.
Infection is a frequent complication and cause of death in
renal failure. Up to 60% of the patients in chronic renal failure
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suffer from a serious infection which, in 38%, contributes to
death [I]. Acute renal failure following trauma or surgery has
many infectious complications [2], therefore, it is not surprising
that most physicians believe the uremic condition itself impairs
immunity and thus predisposes the host to infection. Evidence
for impaired immune capability in uremia can certainly be found
in the literature but, on closer examination, the association
between uremia, depressed immune status, and susceptibility to
infection is far from established. Many reports have been
published in which selected aspects of the immune status of
patients with renal failure were assessed in vitro, but the results
have been conflicting. Some authors [3, 4] reported depressed
function of thymus-derived (T) lymphocytes but others found it
normal [5—7]. The effect of serum factors associated with
uremia on mitogenic stimulation of T lymphocytes has also
varied: Transformation was found to be depressed [8—10],
enhanced [7], or normal [11]. The humoral immune status of
patients with uremia is also controversial: some authors [2, 12,
131 reported normal responses to antigenic stimuli while others
[6, 14, 15] found reduced antibody responses. Assessments of
phagocytic activity of polymorphonuclear leukocytes have
been difficult to compare, but most authors have found little or
no impairment of neutrophil function [16—18]. Chemotaxis has
been reported to be inhibited by uremic serum factors [19, 20]
but again there are other reports of normal chemotaxis in the
presence of serum from uremic patients [21, 22]. There has also
been disagreement on the effect of uremia on the mononuclear
phagocytic system in studies in humans and animals [23—271.
Many variables are associated with the clinical management
of uremic patients including the etiology of renal disease and the
therapeutic measures undertaken, such as renal transplanta-
tion, hemodialysis, continuous ambulatory peritoneal dialysis
(CAPD), and the use of immunosuppressive drugs. In effect,
most clinical studies to date have characterized selectively the
immune status of the patient with endstage renal disease but
failed to comment specifically on the immunomodulatory effect
of uremia. As a result, the contribution of uremia itself to the
observed reduced immune function is difficult to assess.
We have recently used a carefully characterized model of
chronic uremia [28] to define the effects of uremia per se on
immune mechanisms. The model presents many advantages in
that it standardizes or eliminates the variables that complicate
66
related studies in humans. Any analysis of immune competency
in the uremic host, however, is still only an indirect measure of
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host ability to limit the spread of infection. Challenge of the
uremic host with viable microorganisms is the most direct
approach to the assessment of immune capability and our
procedure for the experimental induction of uremia in rats
provided a suitable model in which these definitive experiments
could be carried out. Respiratory infection, bacteremia, perito-
nitis, or subcutaneous infection were established in animals
with chronic severe uremia and normal animals to determine
the effect of uremia on the course of the infection.
Methods
Animals. Male and female rats obtained from an inbred strain
(DA), weighing between 200 and 250 g, were used in these
experiments.
Induction of uremia. Severe stable uremia was induced by
controlled resection of the renal parenchyma involving the
removal of 88% 2% of the renal tissue: the poles, top and 2
mm slices from the dorsal and ventral aspects of the left kidney
were removed, followed by total removal of the right kidney 7
days later. Animals subjected to this treatment had blood urea
levels of greater than 150 mgldl (>25 mmoles/liter) and GFRs of
10 to 20% of normal. Sham-operated animals were used as
controls; the left kidney of each of these animals was surgically
exposed and two thin slices of tissue were removed from the
lateral cortical surface. Seven days later, the right kidney was
surgically exposed and then replaced. These manipulations
duplicated the effects of surgical trauma without affecting renal
function. This procedure has been described in detail elsewhere
[28]. Animals were not used for experimental infections until 4
weeks after the second operation. The blood urea of each
animal was measured at the end of each experiment.
Bacterial strains. Cultures of Pseudomonas aeruginosa and
Klebsiella pneumoniae from clinical samples were obtained
from the Diagnostic Laboratory, Auckland Hospital, Auckland,
New Zealand. The cultures were stored as lyophilized prepara-
tions. The Escherichia coil 075 strain has been used in previous
studies [29, 30].
Experimental infections
Chronic respiratory infection with Pseudomonas aeruginosa
enmeshed in agar beads. This infection was induced in rats
essentially as described by Cash et al [31]. A 9-ml volume of
molten sterile 2% I.D. Agar (Oxoid Ltd., London, United
Kingdom) in phosphate-buffered saline (PBS) was kept at 50°C.
One milliliter of a washed Ps. aeruginosa culture, containing
approximately l0 bacteria, was added to the agar and mixed. A
30-ml volume of sterile liquid paraffin, warmed to 50°C, was
stirred vigorously with a magnetic spin bar and the agar/bacteria
mixture added. After 1 mm of continued stirring, crushed ice
was placed around the vessel containing the agar-in-paraffin
emulsion. Stirring was continued for a further 4 mm, during
which time the agar droplets solidified into beads. Twenty
milliliters of the bead/paraffin mixture were then centrifuged at
1500 rpm for 10 mm. Most of the paraffin was decanted and the
remainder was removed by washing the beads six times in warm
PBS. After the final wash, the beads were resuspended in 4 ml
PBS.
To determine the number of viable bacteria per milliliter of
bead suspension, 1 ml was homogenized in 9 ml of normal saline
and agar pour plates of serial tenfold dilutions of the homoge-
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Fig. 1. Clearance of Ps. aeruginosafrom lungs after direct inoculation
of io bacteria enmeshed in agar beads. Numbers of Ps. aeruginosa
isolated from lungs of sham-operated controls (•) and uremic animals
(A) are compared 1, 5 and 10 days after inoculation. The incidence of
mixed infection in controls (0) and uremic animals (Li) is also
compared.
nate were made. The bead suspension was stored at 4°C
overnight. The next day, after the concentration of viable
bacteria in the prepared bead suspension had been calculated,
the beads were further diluted in PBS to obtain 106 bacteria per
milliliter of bead suspension. Each rat was anesthetized with
ether, a small midline cervical incision was made, and the
trachea was exposed. A curved 18-gauge needle was inserted
into the trachea and, through this, a shortened plastic cannula
(8.0 cm) was pushed down into the base of the lung. Through
this cannula, 100 d of the bead suspension was then introduced
into the lung using a lOO-pi glass microsyringe. Thus each rat
was inoculated with approximately bacteria. After inocula-
tion, the incision was sutured and the rat housed as usual. At
the end of the selected time period, the rats were anesthetized
for collection of blood samples (for measurement of blood urea
only), sacrificed, and the lungs removed for bacteriologic
assessment.
Acute respiratory infection with Klebsiella pneumoniae. This
infection was induced by the inoculation of 100 d of saline
suspension of K. pneumoniae containing 108 bacteria. The
procedure for introducing the bacteria into the lungs was the
same as described above. After the selected time period, the
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Time, hours after inoculation
rats were anesthetized, blood samples for measurement of
blood urea were collected, and the rats were sacrificed for
removal of the lungs for bacteriologic assessment.
Bacteremia with Escherichia coli. Bacteremia was induced
by the injection of i07 viable bacteria in 500 l saline into the
ventral tail vein of each lightly anesthetized rat. At selected
time periods the rats were anesthetized for collection of hepa-
rinized blood samples for the measurement of blood urea and
bacteriology. The animals were then sacrificed to allow bacteri-
ologic assessment of the lungs, spleen, and the median lobe of
the liver.
Peritonitis with Escherichia coli. Peritonitis was induced by
intraperitoneal injection of 2 ml of saline containing 2 x 108
viable bacteria. The injection was made under light anesthesia
into the right lower quadrant of the abdomen [32]. After the
selected time period, each rat was anesthetized to allow collec-
tion of heparinized blood samples for measurement of blood
urea and bacteriology. The animals were then sacrificed, and
the bacteriologic status of the peritoneal cavity, spleen, liver,
and blood was determined.
Infection of subcutaneously implanted sponges with Esche-
richia coli. Cylindrical sponges (2.5 X 1 cm, 40 1 mg) were cut
from polyurethane absorbent foam packing (IC! Tasman Ltd.,
Upper Hutt, New Zealand). The sponges were washed in
distilled water and sterilized by autoclaving in physiological
saline. Before implantation, the saline was removed by squeez-
ing the sponge in a sterile plastic syringe. An incision was made
at either side of the dorsal midline, the facia were retracted by
blunt dissection, and the sponge was implanted in each subcuta-
neous space. Care was taken to observe strict aseptic tech-
niques at all times. Once in place, each sponge was infected
with 500 (± 50) E. coli 075 in 10 til saline and the incision was
closed. At 12, 24, 72, and 96 hr after implantation the sponges
were removed aseptically and weighed. The contained bacteria
were removed by squeezing in 9 ml of saline using a rotating
teflon pestle in a heavily walled glass tube. Nutrient agar pour
plates were made from serial tenfold dilutions to obtain the
bacterial count per sponge after correcting for the amount of
inflammatory fluid in the sponge. The bacterial count was
expressed as the log number of bacteria per sponge (two
sponges per rat).
Determination of bacterial numbers in tissues
Blood. Rats were anesthetized, and a blood sample was
obtained when the heart was punctured using a heparinized 2-
ml syringe and 26-gauge needle. One milliliter of this blood was
diluted immediately 1 in 5 in normal saline and an agar pour
plate made to obtain the bacterial count per milliliter of blood.
The remainder of the blood was set aside for measurement of
blood urea.
Peritoneal cavity. After sacrifice, the skin was retracted to
expose the abdominal wall. Ten milliliters of sterile normal
saline were injected into the peritoneal cavity. The abdomen
was then massaged to ensure even distribution of the fluid. The
saline was retrieved using a syringe and an adapted pediatric
trochar. Agar pour plates of serial tenfold dilutions of the
peritoneal rinse were made to obtain the bacterial count per
milliliter, and a 0. l-ml sample was spread onto blood agar to
check for contamination.
Lungs, liver, and spleen. The abdominal wall and the ribcage
were resected aspectically to expose the thoracic and abdomi-
nal organs. Tissue samples required were removed using asep-
tic procedures and then weighed. The main thoracic blood
vessels were clamped off if the lungs were to be removed.
Where peritonitis had been induced, the spleen and liver lobe
were each rinsed twice in sterile normal saline and blotted to
remove bacteria adhering to their outer surfaces. Tissue sam-
ples were then homogenized in normal saline using a rotating
teflon pestle in a heavily walled glass tube (Tri-R Instruments,
Long Island, New York); spleens and lungs, however, had to be
chopped coarsely with fine scissors to enable them to be
homogenized effectively. Agar pour plates were used to obtain
bacterial numbers as above.
Measurement of blood urea. Plasma or serum was separated
within 30 mm and stored at —20°C until analyses were carried
out. Blood urea was measured using an autoanalyzer (Techni-
con Inc., Tarrytown, New York).
Experimental protocol. Pilot experiments were carried out to
establish the pattern of bacterial elimination in normal animals
challenged with the three pathogens. On the basis of these
cesults, representative intervals were selected for experiments
involving at least 15 uremic and 15 control animals.
Results
Animal model. Serum samples for blood urea analysis were
obtained from all animals on the completion of the experiments.
This was 4 weeks after the second surgical operation (unilateral
nephrectomy) to reduce renal mass. The mean blood urea levels
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Fig. 2. Clearance of K. pneumoniae lung
infection after direct inoculation of 108 bacteria.
A Clearance rate of bacteria from lungs of
normal rats measured 18, 42, 66, and 90 hr after
inoculation. (Range = SEM). B Comparison of
numbers of bacteria in lungs of sham-operated
controls (I) and uremic animals (A) 24 hr after
inoculation.
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Fig. 3. Clearance of E. coli from different tissues after
induction of bacteremia by intravenous injection of IO
bacteria. A Clearance rates in normal animals
measured 2, 4, 16, 24, and 48 hr after inoculation.
(Range = 5EM). B Numbers of E. coli isolated from the
tissue samples of sham-operated controls (•) and
uremic rats (A) 24 hr after inoculation. Mixed infections
(A) were found in lungs of some uremic animals.
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of normal and severely uremic rats were 43.6 8.5 mg/dl and
185.0 74.2 mgldl (7.28 1.42 mmoles/liter and 30.90 12.39
mmoles/liter), respectively. The effect of lung inoculation pro-
cedures on inadvertently produced infections was also investi-
gated. The lungs of 12 uremic and 9 control rats were inoculated
with 100 j.d of sterile saline and the bacteriologic assessment
made 5 days later. Significant numbers of bacteria (mainly a-
hemolytic streptococci) were isolated from the lungs of one
uremic and two control animals, suggesting that the isolation of
mixed organisms could be expected in the subsequent experi-
ments. All lung homogenates were therefore checked on blood
agar. Some lungs were found to be infected with other bacteria
in addition to the experimental strains; in these cases the total
counts from the pour plates were reported as representing
mixed infections.
Chronic respiratory infection with Pseudomonas aeruginosa.
Respiratory infection was established in severely uremic and
sham-operated control animals. Bacterial numbers in the lungs
were determined 1, 5, and 10 days after challenge. At least 15
uremic and 15 control animals were inoculated for examination
at each time period. Bacterial numbers in the lungs of uremic
animals were significantly higher (P < 0.01) than the controls 24
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hr after inoculation (Fig. 1). Five and 10 days after challenge
there was no significant difference (P> 0.1) when we compared
numbers of Ps. aeruginosa in the lungs of uremic and control
animals (Fig. 1); neither was there any significant difference (P
> 0.1) when the total numbers of bacteria recovered from lungs
with mixed infections were compared (Fig. 1).
Acute respiratory infection with Klebsiella pneumoniae. Pre-
liminary experiments were carried out to establish the rate of
clearance of K. pneumoniae from the lungs of normal animals
after direct inoculation of 108 bacteria (Fig. 2A). Severely
uremic and sham-operated control animals were then infected
in the same way and the bacteriologic status of the lungs were
compared 24 hr after inoculation. No significant impairment (P
> 0.1) of the ability of severely uremic animals to clear bacteria
from the lungs could be demonstrated (Fig. 2B).
Bacteremia with Escherichia coli. Experiments were carried
out to determine the clearance rate and organ distribution of E.
coli in normal animals following an intravenous injection of lO
bacteria. These bacteria were cleared rapidly from the blood
and were undetectable by 16 hr after inoculation. The clearance
rates for the spleen, liver, and lungs were slower but, with the
exception of the spleen, bacterial numbers were reduced to low
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Fig. 4. Clearance of E. coli from various
tissue samples after induction ofperitonitis by
intraperitoneal injection of 2 x 108 bacteria.
A Clearance rates in normal animals;
measured 2, 6, 9, 16, 24, and 48 hr after
inoculation. (Range = SEM). B Numbers of E.
coli isolated from tissue samples of sham-
operated controls (•) and uremic rats (A) 24
hr after inoculation.
coli from the peritoneal cavity and numbers of bacteria recov-
ered from tissue samples were similar (P > 0.1) in uremic and
control groups of animals (Fig. 4B).
Clearance of Escherichia coli from subcutaneously implant-
ed sponges. The course of the experimental infection was
followed in 42 severely uremic animals and 40 sham-operated
controls. Bacterial numbers in the sponges were determined 12,
24, 72, and 96 hr after implantation. The volume of inflamma-
tory fluid in each sponge gradually increased, reaching a plateau
after 3 days. There was no difference in the volume of inflam-
matory fluid between the sham and uremic animals at the four
time periods studied. Likewise, when bacterial numbers in the
sponges from the two groups were compared, no significant
difference (P > 0.1) was found (Fig. 5).
Discussion
Renal failure has many infectious complications, and it has
become widely accepted that uremia, itself, impairs immunity
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levels by 48 hr after challenge (Fig. 3A). Twenty-four hours was
chosen as a suitable interval to carry out a comparative study.
No significant difference (P > 0.1) was found when numbers of
E. coli in the blood, lungs, and liver were compared in uremic
and control animals (Fig. 3B). Bacterial numbers in the spleens
of uremic animals, however, were significantly lower (P < 0.01)
than those of the controls (Fig. 3B). Secondary invasion of the
lungs by other bacterial species occurred in 6 of the 18 uremic
animals (33%): The total bacterial counts were 1000-fold higher
than those of lungs infected only with E. coli.
Escherichia coli peritonitis. Peritonitis was induced by inject-
ing 2 x 108 E. coli directly into the peritoneal cavity. The course
of the infection was studied in normal animals by the determina-
tion of viable bacteria in the blood, peritoneal cavity, liver, and
spleen at intervals after inoculation (Fig. 4A). Twenty-four
hours after the challenge was again chosen as an appropriate
interval from which to determine the effect of uremia on the
course of the infection. Uremia did not affect the clearance of E.
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and predisposes the host to infection. The relationship between
uremia, depressed immune status, and susceptibility to infec-
tion, however, has never been clearly established. In previous
experiments using a carefully defined animal model [28] we
examined the effect of chronic uremia on immune status (33—
36); in the present study we used the same animal model to
evaluate the effect of chronic uremia on the susceptibility of the
host to experimentally induced infections. Lung infection,
bacteremia, peritonitis, and subcutaneous infection were evalu-
ated in severely uremic and normal rats. Apart from an initial
slight impairment of the ability of the uremic host to clear a
challenge of Ps. aeruginosa from the lungs, we did not find
significant differences between the two groups in their ability to
combat infection. Interestingly, however, secondary invasion
of the lungs by several other species of bacteria occurred in 33%
of the uremic animals in bacteremia with E. coli; this phenome-
non did not occur in the control group.
Challenge of the uremic host with viable micro-organisms is
obviously the most direct method of assessing the effect of
uremia on susceptibility to infection. It is surprising that, apart
from our own experiments, only one other attempt to study
experimentally induced infections in uremic animals has been
reported. Balch and Evans [37], pursuing their earlier clinical
data that showed an increased infection rate in traumatized
soldiers in renal failure, attempted to mimic the situation in
rabbits. Acute uremia was induced by performing bilateral
nephrectomy; following this the animals were challenged, either
intradermally or intravenously, with one of five different bacte-
ria. Despite the conditions of acute renal failure, their results,
like ours in chronic uremia, failed to show any evidence of a
reduction in host resistance to experimentally induced infec-
tion. Thus, the evidence obtained from experimental models is
that host defence mechanisms restricting bacterial replication
are not affected by uremia.
In our earlier experiments with the rat model of stable
chronic uremia, the effect of uremia on immune status has been
examined in some detail [33—36]. There was a modest and
selective functional depression of several individual immune
components; the results have been summarized in Table 1. One
of the most significant findings was the reduction in catabolic
rate of the reticulo-endothelial system [36]. This could explain
the invasion of the lungs by secondary pathogens in some of the
uremic animals in the bacteremia experiment, as mentioned
above. Overall, the immunosuppression observed in uremia
was relatively selective, comparatively mild, and did not result
in an increase in susceptibility to infection.
The discrepancy between clinical and experimental findings
requires comment. The clinical studies are complicated by
many variables which are difficult to control. These include
renal transplantation, hemodialysis, CAPD, drug therapy, ma!-
nutrition, previous blood transfusions, duration of renal failure,
and surgical manipulations; all of which individually have been
shown to alter the immune response. Thus, uremia is only
one of a number of physiologic and metabolic disturbances
found in renal failure. Factors other than uremia, either individ-
ually or collectively, are more likely to provide the explanation
for the increased infection rate found in chronic uremia. A
report by Ginzler et al [38], who studied the frequency of
infection in patients with systemic lupus erythematosus (SLE)
over a period of 10 years and analyzed the effect of uremia and
of several other factors on the infection rate, supports this view.
Although an increased infection rate was observed in SLE
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Fig. 5. Clearance of E. coil from
subcutaneously implanted sponges which were
infected with 500 50 organisms. These were
removed 12, 24, 72, and 96 hr after
implantation into sham-operated controls (I)
or uremic animals (A) (two sponges per rat).
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Table 1. Effect of uremia on immune status: Summarized results of our recent studies
Antibody response to
selected antigens
Test system
Sheep erythrocytes
Keyhole limpet
Bacteriophage X174
Lipopolysaccharide
Con A response
Mixed ly. culture
Graft vs. host
Host vs. graft
Normal
Normal
Normal
Normal
Mild surgically induced de-
pression
Normal
Moderate surgically induced
depression
Mild depression
Inflammatory re-
sponse
Phagocytosis
Chemotaxis
Complement compo-
nents
Peripheral blood leuco-
cytes
Mononuclear phagocyt-
ic system
Neutrophil function
Mobilization into sub-
cutaneous sponges
CH 50
C3 level
Response to Borde-
tella pertussis
Catabolism of
MjAHSA
Clearance of MIAHSA
Clearance of ØX174
In vivo killing of S.
aureus
In vivo ingestion of la-
tex
Depressed up to 15 hr
Normal
Normal
Normal
Depressed
Normal
Depressed
Normal
Normal
36
36
Generation of immu-
nosuppressive se-
rum factors
Resistance to infec-
tious disease
Experimentally induced
infections
Effect of uremic serum
on Con A response
Lung infections
Bacteremia
Peritonitis
Subcutaneous infec-
tion
Depressed but influenced
by experimental condi-
tions
Some impairment
Normal
Normal
Normal
34
This paper
patients with uremia, once steroid-associated infection was
corrected for, no significant differences between the uremic and
nonuremic groups could be demonstrated. The observations are
of value in that, for the first time in a clinical evaluation, an
appropriate control group was available to assess the effect of
uremia per Se.
Taken overall, it appears reasonable to accept that, although
uremia is a good predictor of future infections, there is no clear
clinical or experimental evidence to show that uremia, itself, is
the primary factor increasing the host's susceptibility to infec-
tious disease.
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